Counsel & Business Executives Gaining Competitive Edge at Collaborative Agreements & Acquisitions

NEW YORK - Jan. 16, 2014 - PRLog -- As life sciences M&A and personalized medicine continue to push deal making trends, ACI’s annual conference is getting quite a bit of attention from biotech, pharma, and device professionals and their industry counsel.  A diverse faculty of business development executives and counsel will be returning to New York, NY for its annual gathering taking place this March 31 – April 2, 2014 at The Carlton Hotel.

This year the industry buzz is all surrounding the new additions to the program that will give attendees enhanced opportunities to gain expert guidance on cutting edge negotiation and deal strategies.  Extended networking breaks and luncheons have been included to in the program to help attendees take advantage of the presence of the nearly two dozen companies slated to attend.

The new pre-conference workshop David and Goliath: Guidance for Smaller Companies on Negotiating with Larger, More Experienced Organizations was designed to address the disparities in leverage and experience that can occur when smaller ventures enter partnerships with larger, more established companies.  Parties of different sizes will come together and discuss how the other side to a negotiation can avoid common missteps and optimize relationship building including guidance on:

· Costs and benefits of connecting early versus waiting until you have pivotal data

· Choosing among collaborative relationship model options

· Understanding differences in paradigm

Another new session on the program this year is How Personalized Medicine Is Transforming Relationships Between Diagnostic and Drug Companies.  ACI is pleased to present a panel that will provide practical tips for addressing the unique challenges shaping partnership considerations in this explosive new field.

According to Krishna Patel, Program Manager with ACI, the importance of attending this conference, now in its 18th year, is higher than it has ever been. “As biotech and pharma business models increasingly rely on the strength and value of partnerships, counsel and business development executives are consistently under pressure to retain valuable product rights while minimizing capital investments and risk.  This event offers a unique range of panels and opportunities to benchmark your practices, gain cutting edge insights into diligence, and to meet your next partner.”

For more information on this session and the overall program, visit

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Headquartered in New York and led by Leigh Gilmore, Senior Vice President, and Seth Kerker, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.

Email:*** Email Verified
Tags:Pharma, Biotech, Life Sciences, Patents, M A
Industry:Health, Medical
Location:New York City - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jan 16, 2014
American Conference Institute PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share